These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12100205)

  • 1. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
    Schanz S; Ulmer A; Rassner G; Fierlbeck G
    Br J Dermatol; 2002 Jul; 147(1):174-8. PubMed ID: 12100205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.
    Pisoni CN; Obermoser G; Cuadrado MJ; Sanchez FJ; Karim Y; Sepp NT; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 2005; 23(3):393-6. PubMed ID: 15971430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different faces of cutaneous lupus erythematosus.
    Renner R; Sticherling M
    G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil and systemic lupus erythematosus: an overview.
    Pisoni CN; Karim Y; Cuadrado MJ
    Lupus; 2005; 14 Suppl 1():s9-11. PubMed ID: 15803925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil and skin diseases.
    Hartmann M; Enk A
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
    Kreuter A; Tomi NS; Weiner SM; Huger M; Altmeyer P; Gambichler T
    Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.
    Mok CC
    Scand J Rheumatol; 2007; 36(5):329-37. PubMed ID: 17963161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mycophenolate mofetil on cutaneous lupus erythematosus in (NZB × NZW) F1 mice.
    Lee YF; Cheng CC; Lan JL; Hsieh TY; Lin NN; Lin HY; Chiu YT
    J Chin Med Assoc; 2013 Nov; 76(11):615-23. PubMed ID: 23968808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
    Kouba DJ; Mimouni D; Rencic A; Nousari HC
    Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus.
    Mak A; Mok CC
    Lupus; 2005; 14(10):856-8. PubMed ID: 16302683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in lupus nephritis.
    Ginzler EM; Aranow C
    Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C; Crowson CS; Matteson EL; Moder KG
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy.
    Nawata T; Kubo M; Fujii S; Shiragami K; Ikegami T; Kobayashi S; Hisano S; Yano M
    Intern Med; 2018 Jul; 57(14):2067-2070. PubMed ID: 29491296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenylate mofetil: what role in the treatment of lupus?
    Dooley MA
    Lupus; 2006; 15(3):179-82. PubMed ID: 16634373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.